It looks like PharmAthene (PIP +7.7%) investors will be in for another roller coaster of a...

|By:, SA News Editor

It looks like PharmAthene (PIP +7.7%) investors will be in for another roller coaster of a session as the stock jumps out of the gate after the FDA lifts its clinical hold on the company's SparVax vaccine program. (Recently: PIP/SIGA claim legal victory) (PR)